The popularity of Sildenafil initially drove a surge for major pharmaceutical companies, but recent shifts present a uncertain picture for shareholders. Generic competitors are eroding revenue, and persistent legal https://jasongunv724382.tkzblog.com/40941508/sildenafil-and-pharma-a-volatile-bet